Alexandra Drakaki

Hematology

5767 W Century Blvd Ste 400
Los Angeles, CA 90045

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.

Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.

Journal: JCO oncology practice

Published: August 18, 2026

A Case Report of a 64-Year-Old Man With Urothelial Carcinoma With Brain and Leptomeningeal Metastases Treated With Intrathecal Methotrexate as Part of Multimodal Management.

A Case Report of a 64-Year-Old Man With Urothelial Carcinoma With Brain and Leptomeningeal Metastases Treated With Intrathecal Methotrexate as Part of Multimodal Management.

Journal: The American journal of case reports

Published: August 17, 2026

Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Journal: Nature

Published: August 05, 2026

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 14, 2026

TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

Journal: Future oncology (London, England)

Published: May 16, 2026

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.

Journal: Cancers

Published: April 01, 2026

Threading the Needle in Bladder Cancer: A Narrative Review of the Emerging Role of Integrative Oncology in Treatment-Related Adverse Events in the Era of Immunotherapy and Antibody-Drug Conjugates.

Threading the Needle in Bladder Cancer: A Narrative Review of the Emerging Role of Integrative Oncology in Treatment-Related Adverse Events in the Era of Immunotherapy and Antibody-Drug Conjugates.

Journal: Cureus

Published: March 22, 2026

Long-Term Survival After Percutaneous Image-Guided Thermal Ablation of Oligometastatic Renal Cell Carcinoma.

Long-Term Survival After Percutaneous Image-Guided Thermal Ablation of Oligometastatic Renal Cell Carcinoma.

Journal: Journal of vascular and interventional radiology : JVIR

Published: March 19, 2026

First, Do No Harm.

First, Do No Harm.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 13, 2026

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

Journal: Nature

Published: February 16, 2026

A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis.

A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis.

Journal: bioRxiv : the preprint server for biology

Published: February 06, 2026

Multi-level transcriptional control of specific macrophage responses.

Multi-level transcriptional control of specific macrophage responses.

Journal: The EMBO journal

Published: January 16, 2026

Showing 1-12 of 140

Last Updated: 09/26/2026